Literature DB >> 307393

Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice.

F J Dixon, B S Andrews, R A Eisenberg, P J McConahey, A N Theofilopoulos, C B Wilson.   

Abstract

Two recently described murine strains, MRL/1 and BXSB, develop a lupus-like syndrome resulting in a 50% mortality by the fifth month of age. Comparison of the immunopathological and virological characteristics of these mice with those of the NZB/NZW F1 mouse reveals several pathogenetic common denominators but no obvious common etiologic factors. In all three kinds of mice, the lupus-like syndrome consists of a fatal immune complex type glomerulonephritis and complete or near complete thymic cortical atrophy plus lymphoid hyperplasia that varies in degree among the three kinds of mice. The nephritic glomeruli contain a concentration of antinuclear antibodies plus varying amounts of stainable gp70. This syndrome is consistently correlated with abnormally elevated serum IgG levels, antinuclear antibodies, anti ds- and ssDNA antibodies, and circulating immune complexes, as well as depressed serum hemolytic complement. Features that differ among the three kinds of mice include: H2 type, anti-lymphocyte antibody, cryoglobulins, T-B cell ratios, sex incidence of disease, vasculitis, and oncornaviral flora. The serum gp70 levels in the three mice also differ considerably, but all are within the range of gp70 levels found in some immunologically normal strains.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307393     DOI: 10.1002/art.1780210909

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

Review 1.  A model for lupus brain disease.

Authors:  Betty Diamond; Bruce T Volpe
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Sustained Immunosuppression Alters Olfactory Function in the MRL Model of CNS Lupus.

Authors:  Minesh Kapadia; Hui Zhao; Donglai Ma; Boris Sakic
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-11       Impact factor: 4.147

Review 3.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

4.  A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis.

Authors:  Sarah Bradshaw; W Jim Zheng; Lam C Tsoi; Gary Gilkeson; Xian K Zhang
Journal:  Clin Immunol       Date:  2008-08-09       Impact factor: 3.969

Review 5.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

6.  The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G.

Authors:  P Jeddi; J Keusch; P M Lydyard; K B Bodman-Smith; M S Chesnutt; D Wofsy; H Hirota; T Taga; P J Delves
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

7.  In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus.

Authors:  Yulia Vugmeyster; Heath Guay; Pamela Szklut; Ming D Qian; Macy Jin; Angela Widom; Vikki Spaulding; Frann Bennett; Leslie Lowe; Tatyana Andreyeva; David Lowe; Steven Lane; George Thom; Viia Valge-Archer; Davinder Gill; Deborah Young; Laird Bloom
Journal:  MAbs       Date:  2010-05-23       Impact factor: 5.857

Review 8.  Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives.

Authors:  Eva Schrezenmeier; David Jayne; Thomas Dörner
Journal:  J Am Soc Nephrol       Date:  2018-01-11       Impact factor: 10.121

9.  TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.

Authors:  Kevin M Nickerson; Sean R Christensen; Jonathan Shupe; Michael Kashgarian; Daniel Kim; Keith Elkon; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

Review 10.  Mechanisms of autoimmunity.

Authors:  Robert Eisenberg
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.